Cargando…

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Detalles Bibliográficos
Autores principales:	Souchet, Benoit, Audrain, Mickael, Billoir, Baptiste, Lecanu, Laurent, Tada, Satoru, Braudeau, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879886/ https://www.ncbi.nlm.nih.gov/pubmed/29557364 http://dx.doi.org/10.4103/1673-5374.226389

Ejemplares similares

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
por: Souchet, Benoît, et al.
Publicado: (2019)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Rethinking Opsins
por: Feuda, Roberto, et al.
Publicado: (2022)

Drugs for solid cancer: the productivity crisis prompts a rethink
por: Rösel, Daniel, et al.
Publicado: (2013)

Rethinking COVID-19 test sensitivity-a strategy for improving the detection limit
por: Akhtar, Mohammed Kalim, et al.
Publicado: (2021)

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain
por: Orefice, Nicola Salvatore, et al.
Publicado: (2019)

Diversity and Inclusion in Drug Development: Rethinking Intrinsic and Extrinsic Factors with Patient Centricity
por: Venkatakrishnan, Karthik, et al.
Publicado: (2021)

Rethinking 3D-QSAR
por: Cramer, Richard D.
Publicado: (2010)

Rethinking the INN system for therapeutic antibodies
por: Pottier, Jérémy, et al.
Publicado: (2016)

Rethinking the pathway to sustainable fire retardants
por: Feng, Jiabing, et al.
Publicado: (2023)

Silent Synapse-Based Circuitry Remodeling in Drug Addiction
por: Dong, Yan
Publicado: (2015)

Why We Need to Rethink the Diseases of Affluence
por: Novotny, Thomas E
Publicado: (2005)

Rethinking Ecosystem Resilience in the Face of Climate Change
por: Côté, Isabelle M., et al.
Publicado: (2010)

Rethinking the approach to viability monitoring in seed genebanks
por: Hay, Fiona R., et al.
Publicado: (2017)

Rethinking Cultural Competence: Shifting to Cultural Humility
por: Lekas, Helen-Maria, et al.
Publicado: (2020)

Rethinking resilience and development: A coevolutionary perspective
por: Haider, L. Jamila, et al.
Publicado: (2021)

Health as activism: rethinking social medicine in India
por: Chakrabarti, Pratik
Publicado: (2022)

Modeling Alzheimer's disease with non-transgenic rat models
por: Lecanu, Laurent, et al.
Publicado: (2013)

Rethinking the Body in the Brain after Spinal Cord Injury
por: Leemhuis, Erik, et al.
Publicado: (2022)

Rethinking Benefits in Health Research, Reflections of an Ethics Committee
por: Mondragón Barrios, Liliana, et al.
Publicado: (2022)

Neurodevelopmental disorders—high-resolution rethinking of disease modeling
por: Khodosevich, Konstantin, et al.
Publicado: (2022)

Rethinking domain adaptation for machine learning over clinical language
por: Laparra, Egoitz, et al.
Publicado: (2020)

The silent loss of cell physiology hampers marine biosciences
por: Melzner, Frank, et al.
Publicado: (2022)

Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
por: Morens, David M., et al.
Publicado: (2023)

Rethinking CSR theory to incorporate microbial metabolic diversity and foraging traits
por: Wood, J. L., et al.
Publicado: (2023)

Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
por: Tonali, Nicoló, et al.
Publicado: (2021)

Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer’s Disease Diagnosis
por: Rammouz, Georges, et al.
Publicado: (2011)

Is Carotid Body Infection Responsible for Silent Hypoxemia in COVID-19 Patients?
por: Villadiego, Javier, et al.
Publicado: (2020)

Rethinking Alzheimer’s Disease
por: de Mendonça, Alexandre
Publicado: (2012)

A cornerstone of healthy aging: do we need to rethink the concept of adherence in the elderly?
por: Giardini, Anna, et al.
Publicado: (2018)

Taking data seriously: the value of actor-network theory in rethinking patient experience data
por: Desai, Amit, et al.
Publicado: (2017)

Chronic Conditions and Behavioural Change Approaches to Medication Adherence: Rethinking Clinical Guidance and Recommendations
por: Read, Simon, et al.
Publicado: (2020)

Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care
por: Greenhawt, Matthew, et al.
Publicado: (2020)

Poverty eradication and food security through agriculture in Africa: Rethinking objectives and entry points
por: Gassner, A, et al.
Publicado: (2019)

The European Commission’s Green Deal is an opportunity to rethink harmful practices of research and innovation policy
por: Bernstein, Michael J., et al.
Publicado: (2022)

The Silent Majority: Limited Health Literacy Participants Missing from Market Research
por: Stone, William, et al.
Publicado: (2018)

Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism
por: Hoskisson, Paul A., et al.
Publicado: (2020)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Rethinking Strategy
por: Tighe, Steve
Publicado: (2019)

Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
por: Audrain, Mickael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_omcdmntfs2394vkqdlooeva93m